1. Home
  2. LGND vs APPN Comparison

LGND vs APPN Comparison

Compare LGND & APPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • APPN
  • Stock Information
  • Founded
  • LGND 1987
  • APPN 1999
  • Country
  • LGND United States
  • APPN United States
  • Employees
  • LGND N/A
  • APPN N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • APPN Computer Software: Prepackaged Software
  • Sector
  • LGND Health Care
  • APPN Technology
  • Exchange
  • LGND Nasdaq
  • APPN Nasdaq
  • Market Cap
  • LGND 2.0B
  • APPN 2.3B
  • IPO Year
  • LGND 1992
  • APPN 2017
  • Fundamental
  • Price
  • LGND $108.55
  • APPN $30.69
  • Analyst Decision
  • LGND Strong Buy
  • APPN Hold
  • Analyst Count
  • LGND 7
  • APPN 8
  • Target Price
  • LGND $144.67
  • APPN $33.00
  • AVG Volume (30 Days)
  • LGND 116.1K
  • APPN 652.7K
  • Earning Date
  • LGND 05-08-2025
  • APPN 05-08-2025
  • Dividend Yield
  • LGND N/A
  • APPN N/A
  • EPS Growth
  • LGND N/A
  • APPN N/A
  • EPS
  • LGND N/A
  • APPN N/A
  • Revenue
  • LGND $167,133,000.00
  • APPN $617,022,000.00
  • Revenue This Year
  • LGND $16.47
  • APPN $12.27
  • Revenue Next Year
  • LGND $19.44
  • APPN $10.15
  • P/E Ratio
  • LGND N/A
  • APPN N/A
  • Revenue Growth
  • LGND 27.28
  • APPN 13.14
  • 52 Week Low
  • LGND $69.17
  • APPN $24.00
  • 52 Week High
  • LGND $129.90
  • APPN $43.33
  • Technical
  • Relative Strength Index (RSI)
  • LGND 53.94
  • APPN 59.16
  • Support Level
  • LGND $101.24
  • APPN $25.34
  • Resistance Level
  • LGND $111.39
  • APPN $27.11
  • Average True Range (ATR)
  • LGND 5.67
  • APPN 1.60
  • MACD
  • LGND 0.82
  • APPN 0.45
  • Stochastic Oscillator
  • LGND 84.05
  • APPN 96.61

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About APPN Appian Corporation

Appian Corp is a low-code enterprise platform-as-a-service company focusing on business process management. The company's Appian platform is an integrated automation platform providing tools for organizations to design, automate, and optimize end-to-end processes and complex business operations. Capabilities include case management, robotic process automation, artificial intelligence, data fabric, and process mining. The company also provides maintenance and support as well as consulting services and training related to its platform. The majority of its revenue is subscription-based with the remainder from services, with much of its subscription revenue being derived from its cloud-based platform. Geographically, the company derives maximum revenue from its business in the United States.

Share on Social Networks: